Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of istaroxime in acute decompensated heart failure
2008-003531-21Phase 2Terminated
- Sponsor
- Debiopharm
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of istaroxime in heart failure (HF) (4 arms), sponsored by Debiopharm. Primary endpoints: Hemodynamic effects of istaroxime, Clinical efficacy and safety and 1 more. Started Aug 2008; status: terminated.
02
Drugs
istaroxime
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-003531-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003531-21.